AAAAAA

   
Results: 1-12 |
Results: 12
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)
Authors: Parra, HS Tixi, L Latteri, F Bretti, S Alloisio, M Gravina, A Lionetto, R Bruzzi, P Dani, C Rosso, R Cosso, M Balzarini, L Santoro, A Ardizzoni, A
Citation: Hs. Parra et al., Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP), CANCER, 92(3), 2001, pp. 650-656
Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study
Authors: Ardizzoni, A Antonelli, G Ricci, S Frasci, G Rinaldi, M Boni, L Galletti, P Pennucci, MC Antonuzzo, A Gravina, A Galli, L Comella, G Conte, PF Salvati, F Rosso, R
Citation: A. Ardizzoni et al., Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study, AM J CL ONC, 23(1), 2000, pp. 22-25
Phase I-II study of gemcitabine and paclitaxel in pretreated patients withstage IIIB-IV non-small cell lung cancer
Authors: Iaffaioli, RV Tortoriello, A Gravina, A Facchini, G Turitto, G Elia, S Griffo, S Gentile, M Fraioli, G Frattolillo, A Muto, P Libutti, M De Marino, V Illiano, A Barbarisi, A
Citation: Rv. Iaffaioli et al., Phase I-II study of gemcitabine and paclitaxel in pretreated patients withstage IIIB-IV non-small cell lung cancer, LUNG CANC, 30(3), 2000, pp. 203-210
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group
Authors: Daponte, A Ascierto, PA Gravina, A Melucci, MT Palmieri, G Comella, P Cellerino, R DeLena, M Marini, G Comella, G
Citation: A. Daponte et al., Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group, CANCER, 89(12), 2000, pp. 2630-2636
Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer
Authors: Caponigro, F Avallone, A McLeod, H Carteni, G De Vita, F Casaretti, R Morsman, J Blackie, R Budillon, A De Lucia, L Gravina, A Catalano, G Comella, P Comella, G
Citation: F. Caponigro et al., Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer, CLIN CANC R, 5(12), 1999, pp. 3948-3955
A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin
Authors: Conte, P Ricci, S Antonuzzo, A Allegrini, G Palazzo, S Liguori, V Mastroianni, C Manzione, L Bilancia, D Dinota, A Di Costanzo, F Gasperoni, S Sdrobolini, A Montinari, F Mastore, M Casartelli, C Danese, S Richiardi, G Sismondi, P Locatelli, MC D'Antona, A Luporini, G Ambrosini, G Giustini, L Bascioni, R Acito, L Recchia, F De Filippis, S Rosselli, M Vinante, O Rossetti, F Azzarello, G Lucenti, A Galligioni, E Brugnara, S Rossi, A al Vesuvio, SS Bumma, C Donadio, M Cattaneo, MT Aapro, MS Libretti, A Nole, F Bizzarri, M Facco, R Buzzi, F Brugia, M Colucci, G Giotta, F Manente, P Vicario, G Martoni, A Angelelli, B Pusceddu, G Salaris, G Comella, G Gravina, A Morrica, B Rampello, G Colosini, G Migliosi, G Temperilli, L Monno, D Amadori, D Maltoni, M Ammuni, G Villanucci, A Cocconi, G Bella, M Farris, A Sanna, G Gebbia, V Testa, A Iacono, G LoPresti, G Pergola, M Gridelli, C Adamo, V Altavilla, G Barbieri, P Pisoni, G
Citation: P. Conte et al., A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin, ANTI-CANC D, 10(5), 1999, pp. 465-470
Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?
Authors: Ruggeri, B Ballatori, E Casali, P Tamburini, M Licitra, L Mencaglia, E Roila, F Cortesi, E Massidda, B Costantini, M De Angelis, V Ciccarese, G Mattei, A Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S De Angelis, V Ciccarese, G Milella, G Bruno, ML Basurto, C Locatelli, MC Valsecchi, R Zamparelli, G Pessi, A Molaro, O Luporini, G Giovanni, S Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Timio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Giovanni, S Maluta, S Selvestrel, C Cognetti, F Barduagni, M Fusco, V Rossi, M Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Deplacido, S Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Marcellini, M
Citation: B. Ruggeri et al., Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?, ANN ONCOL, 10(9), 1999, pp. 1095-1100
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma:A phase I study of the Southern Italy Cooperative Oncology Group
Authors: Comella, P Casaretti, R De Vita, F Avallone, A Orditura, M Petrillo, A Gravina, A Faranda, A Comis, S Comella, G Catalano, G
Citation: P. Comella et al., Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma:A phase I study of the Southern Italy Cooperative Oncology Group, ANN ONCOL, 10(8), 1999, pp. 915-921
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study
Authors: Frasci, G Panza, N Comella, P Carteni, G Guida, T Nicolella, GP Natale, M Lombardi, R Apicella, A Pacilio, C Gravina, A Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study, ANN ONCOL, 10(3), 1999, pp. 355-358
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer
Authors: Iaffaioli, RV Tortoriello, A Facchini, G Capenigro, F Gentile, M Marzano, N Gravina, A Dimitri, P Costagliola, G Ferraro, A Ferrante, G De Marino, V Illiano, A
Citation: Rv. Iaffaioli et al., Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer, J CL ONCOL, 17(3), 1999, pp. 921-926
Patient compliance with quality of life questionnaires
Authors: Roila, F Ballatori, E Mattei, A Cortesi, E Tamburini, M Casali, P Licitra, L Mencaglia, E Costantini, M Massidda, B De Angelis, V Ciccarese, G Valori, VM Lelli, G Nanni, L Romano, MP Di Maggio, G Morritti, MG Di Micco, C Palladino, MA Porrozzi, S Milella, G Locatelli, MC Valsecchi, V Zamparelli, G Pessi, A Molaro, O Luporini, G Bertetto, O Donadio, M Fanchini, L Mistrangelo, M Bumma, C Parello, G Malacarne, P Donati, D Scapoli, D Ferrari, A Olmi, P Galardi, A Panichi, M Ruggiero, C Zironi, S Banzi, C Piccinini, L Campora, E Venturino, A Vincenti, M Gasco, M Marchioro, G Barbato, F Azzarello, G Vinante, O Sabbioni, R Nortilli, R Griso, C Cetto, L Aste, MG Pasqualucci, S Chierchi, MC Floris, C Barbieri, E Frezza, G Bunkeila, F Bonci, F Sarobba, MG Farris, A Sanna, G Ionta, MT Murru, R Mascia, MG Lopez, M Amodio, A Paoletti, G Tomio, L Romano, M Amichetti, M Barni, S Ardizzoia, A Mandala, M Maxia, G Dessi, M Acito, L Giustini, L Casarini, MB Smerieri, F Riva, N Maltoni, M Antimi, M Bellini, V Boz, G Brema, F Mencaglia, E De Candis, D Polico, C Mandoliti, G Amendola, P Iacono, C Imperato, A Gelmi, S Maluta, S Selvestrel, C Giovanni, S Cognetti, F Barduagni, M Fusco, V Pozzi, G Bracci, R Antognoli, S Mascia, V Farci, D Vitale, V Musi, M Grasso, F Nicodemo, M Cirillo, M Botta, M De Giovanni, D Giuliodori, L Silva, RR Martignetti, A Domini, P Gareri, R Porcile, G Dalla Mola, A Ambrosini, G Casi, C Del Favero, A Pignata, S Ricchi, P Folco, U Castellana, MA Salvi, G Lionello, R Gaion, F Ronco, M Troccoli, G Ranuzzi, M Marchetti, P Montinari, F Fioretto, L Palmeri, S Sassi, M Carreca, I Cinieri, S Graiff, C Cariello, S Mantovani, G Lazzaro, B Spada, S Rosati, G De Marinis, F Gravina, A La Ciura, P Ognibeni, M Iannone, T Pusceddu, G Buffoli, A Menichetti, ET
Citation: F. Roila et al., Patient compliance with quality of life questionnaires, TUMORI, 85(2), 1999, pp. 92-95
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
Authors: Caponigro, F Comella, P Marcolin, P Spena, FR Biglietto, M Carteni, G De Lucia, L Avallone, A Gravina, A Comella, G
Citation: F. Caponigro et al., A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck, CANCER, 85(4), 1999, pp. 952-959
Risultati: 1-12 |